卡氏肺孢子虫疫苗研究进展
被引量：2
Study on Construction and its Immune Mechanism of Recombinant BCG Vassine of Schistosome
摘要
卡氏肺孢子虫疫苗是预防和治疗卡氏肺孢子虫肺炎的一种途径。本文综述了卡氏肺孢子虫死疫苗、活疫苗和分子疫苗的研究进展。
出处
《热带医学杂志》
CAS
2002年第3期280-283,共4页
Journal of Tropical Medicine
基金
重庆市卫生局自然科学基金 (No .2 0 0 2 - 0 8)
参考文献25
-
1Ma L, Borio L, Masur H, et al.Pneumocystis carinii dihydr opteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use[J].J Infect Dis,1999 ;180(6):1969-1978
-
2Walzer PD. Immunopathogenesis of Pneumocystis carinii infection[ J].J Lab Clin Med,1991;118:206-216
-
3Beck JM, Harmsen AG. Lymphocytes in host defense against Pneumocyst is carinii[J].Semin Respir Infect,1998;13:330-338
-
4Pifer LL, Pifer DD, Woods DR,et al.Preliminary studies on the dev elopment of a vaccine for Pneumocystis carinii: I Immunological and biochem ical characterization[J].Vaccine,1986;4:257-265
-
5Pascale JM, Shaw MM, Durant PJ, et al. Intranasal immunization co nfers protection against murine Pneumocystis lung infection[J]. Infect Immun , 1999;67:805-809
-
6Harmsen AG, Chen WX, Gigliotti F,et al. Active immunity to Pneu mocystis carinii reinfection in T-cell-depleted mice[J]. Infect Immun, 1995;63(7): 2391-2395
-
7Garvy BA, Wiley JA, Gigliotti F, et al. Protection against Pneu mocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses[J]. Infect Immun, 1997;65: 5052-5056
-
8Smulian AG, Stringer JR, Linke MJ, et al. Isolation and character ization of a recombinant antigen of Pneumocystis carinii[J]. Infect Immu n, 1992;60:907-915.
-
9Smulian AG, Theus SA, Denko N, et al. A 55KDa antigen of Pneumo cystis carinii: Analysis of cell mediated immune response and characterization of the gene[J]. Mol Microbiol, 1993;7:745-753
-
10Smulian AG, Sullivan DW, Theus SA. Immunization with recombina nt Pneumocystis carinii P55 antigen provides partial protection against infe ction:characterization of epitope recogintion associated with immunization[J]. Microbes Infect, 2000;2:127-136
同被引文献14
-
1孙建宏,曹殿军.细胞的抗原表位研究方法[J].动物医学进展,2004,25(5):18-21. 被引量：10
-
2陈雅棠.卡氏肺孢子虫病诊断治疗进展[J].临床内科杂志,1995,12(4):11-13. 被引量：5
-
3施晓华.卡氏肺孢子虫肺炎的预防和治疗进展[J].国外医学（寄生虫病分册）,1996,23(2):57-60. 被引量：10
-
4Gigliotti F, Haidaris CG, Wright TW, et al. Passive intranasal monoclonal antibady prophylaxis against murine Pneumocystis carinii pneumonia[J]. Infect Immun, 2002, 20 (3): 1069-1074.
-
5Poland GA, Ovsyannikova IG, Johnson KL, Naylor S. The role of mass spectrometry in vaccine development[J]. Vaccine. 2001, 19: 2691-2700.
-
6Huang SN, Angus CW, Turner RE, et al. Identification and characterization of novel variant major surface glycoprotein gene families in rat Pneumocystis carinii[J]. Infect Dis, 1999, 179 (1): 192- 200.
-
7Rammensee H, Bachmarm J, Emmerich NP, Bachor OA, Stevanovi S. SYFPEITHI: database for MHC ligands and peptide motifs [J].Immunogenetics, 1999, 50 (3-4): 213-219.
-
8曾丽,杨培志,杨亮宇,杨月中.几种药物对实验大鼠卡氏肺孢子虫肺炎的疗效试验[J].中国兽医科技,1999,29(10):29-31. 被引量：1
-
9叶彬,陈雅棠,刘成伟.双氢青蒿素对卡氏肺孢子虫超微结构的影响[J].中国人兽共患病杂志,2000,16(4):21-24. 被引量：41
-
10吴敬,吴梧桐.B细胞蛋白质抗原表位的研究方法进展[J].药物生物技术,2000,7(4):239-242. 被引量：25
-
1吴雨.何谓死疫苗、活疫苗?[J].健康必读,2004(3):23-23.
-
2晓夫.前景广阔的新型疫苗——分子疫苗[J].国际医药卫生导报,1998,4(12):30-30.
-
3赵跃武,赵凤兰,徐友梅,胡军.鼠伤寒沙门氏菌外膜蛋白诱发BALB／C小鼠免疫保护的研究[J].中国微生态学杂志,1996,8(4):7-10.
-
4李文桂,陈雅棠.细粒棘球绦虫疫苗研究进展[J].中国地方病学杂志,2003,22(6):564-566. 被引量：9
-
5方艳辉,肖丽君,金玉怀.增强核酸疫苗免疫效力的策略及相关机制[J].承德医学院学报,2004,21(3):248-250.
-
6张世勇,高秋菊,张勇,侯通,夏建玲,刘新立.甲型肝炎减毒活疫苗与麻疹减毒活疫苗联合免疫的实验研究[J].中华流行病学杂志,2001,22(5):351-351. 被引量：1
-
7喻启桂,汪美先.单纯疱疹病毒分子疫苗的研究进展[J].国外医学（免疫学分册）,1989,12(6):283-286. 被引量：2
-
8周芹芝,李曼,陈鹤,都建,罗庆礼,沈继龙.弓形虫ROP16_(Ⅰ/Ⅲ)DNA疫苗不能诱导小鼠有效的保护性免疫[J].中国人兽共患病学报,2015,31(11):1010-1016. 被引量：1
-
9邢梦龙.核酸疫苗[J].上海食品药品监管情报研究,1999,0(1):3-4.
-
10陈翠萍,王秉瑞.幽门螺杆菌疫苗及动物模型的研究进展[J].微生物学免疫学进展,2001,29(1):66-68. 被引量：1
